Iovanace Biotherapeutics (IOVA) PT Lowered to $35 at Piper Sandler
May 19, 2021 11:01 AM
Piper Sandler analyst Joseph Catanzaro lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $35.00 (from $45.00) while maintaining a Overweight rating.
